BioSpace News Archive

StartX, a non-profit startup community of more than 1500 Stanford alumni and faculty founders, will gather StartX Med’s leading-edge biotech, med device, AI, deep learning and digital health companies together with corporate partners and invited guests attending the J.P. Morgan Healthcare Conference in San Francisco.

The New Jersey Department of Banking and Insurance announced on Jan. 6 that it awarded GetInsured, a health insurance marketplace platform provider, a five-year contract to develop and operate the technology to transition from the federal marketplace to a state-based exchange.

BioForward, Wisconsin’s state association representing over 220 biohealth member companies, announced seven additions to this year’s Board of Directors.

Preclinical results published in Science Translational Medicine show that adding CD28 costimulatory bispecifics to CD3 bispecifics led to synergistic anti-tumor activity without inducing cytokine storm

Technavio has announced its latest market research report titled global middle ear implants market 2019-2023.

KBP BioSciences announced that Thijs Spoor, Chief Executive Officer, will present at the Biotech Showcase, being held January 13-15, 2020 in San Francisco.

Technavio announced its latest market research report titled global ophthalmic knives market 2019-2023.

Astellas Pharma Inc. announced that the U.S. Food and Drug Administration has approved its supplemental New Drug Application for MYCAMINE® in support of the treatment of Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses without meningoencephalitis and/or ocular dissemination in pediatric patients younger than 4 months of age.

The company will hold a question and answer session immediately following the presentation.

The conference will take place January 13-16, 2020, at the Westin St. Francis Hotel in San Francisco.